AstraZeneca
AZN
AZN
1,228 hedge funds and large institutions have $39.1B invested in AstraZeneca in 2024 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 498 increasing their positions, 398 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $39B → $39.1B (+$45.6M)
0.07% more ownership
Funds ownership: 32.22% → 32.29% (+0.07%)
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
Holders
1,228
Holding in Top 10
17
Calls
$485M
Puts
$334M
Top Buyers
| 1 | +$808M | |
| 2 | +$200M | |
| 3 | +$130M | |
| 4 |
D.E. Shaw & Co
New York
|
+$126M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$123M |
Top Sellers
| 1 | -$268M | |
| 2 | -$197M | |
| 3 | -$188M | |
| 4 |
Jennison Associates
New York
|
-$166M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$165M |